public health
play

PUBLIC HEALTH Stacy Kancijanic, MA DEFINITIONS Counterfeit - PowerPoint PPT Presentation

QUALITY OF MEDICINES IN PUBLIC HEALTH Stacy Kancijanic, MA DEFINITIONS Counterfeit medicine is one that infringes on a registered trademark. Substandard drugs fail to meet the specifications outlined by an accepted pharmacopeia or the


  1. QUALITY OF MEDICINES IN PUBLIC HEALTH Stacy Kancijanic, MA

  2. DEFINITIONS  Counterfeit medicine is one that infringes on a registered trademark.  Substandard drugs fail to meet the specifications outlined by an accepted pharmacopeia or the manufacturer’s dossier.  Falsified drugs are those that carry false representation of identity or source . IOM Report, Countering the Problem of Falsified and Substandard Drugs, 2013

  3. SUBSTANDARD MEDICINES  30-60% of the medicine supply in Africa and SE Asia is substandard*  Failure to adhere to GMPs root cause  an astonishing number of bad drugs reach patients through legitimate supply chains  degraded through bad storage  once a manufacturer has obtained quality certification, it is relatively easy to sell the drug at a lower quality in countries with weak regulations *International Policy Network

  4. COUNTERFEIT RX  antimicrobials and antiparasitics are the 2 types of pharma products most counterfeited in developing countries  Estimated 80% of counterfeit drugs come from overseas

  5. PUBLIC HEALTH CONSEQUENCES  Lack of therapeutic effect may lead to prolonged illness or death  May include toxic or adverse reaction  Encourages drug resistance  Wastes money  Causes consumers to lose confidence in health care system and national regulatory agencies.

  6. CAUSES OF POOR OUTCOMES IN PHARMA PRODUCT INTEGRITY  below-standard supply chain or cold chain processes,  production or handling (substandard medicines),  deliberate mislabeling (counterfeit products), or  from poor storage conditions or inappropriate distribution

  7. Upstream Supply Chain Security Source: Rx-360 Upstream Supply Chain Security White Paper, 2013.

  8. SUPPLY CHAIN VULNERABILITIES Source: Pew Health Group

  9. DRUG DISTRIBUTION SYSTEM

  10. WSJ: AFRICA’S MALARIA BATTLE

  11. WWARN ONLINE DRUG QUALITY MAP

  12. GENERIC DRUGS LANDSCAPE  Around 80% of the drug substances and 40% of the drug products sold in the US are imported, most from India and China  All antibiotics sold in the US are imported  FDA’s ability to inspect outside the US is limited  Some require advanced warning vs. unannounced inspections in the US – India now has unannounced inspections  Some countries like China make obtaining visas for FDA inspectors very difficult – FDA now stationing people in China

  13. INTL STANDARDS  WHO  http://apps.who.int/prequal/  developing a system for the global surveillance and monitoring of falsified and substandard drugs.  International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH)  Q10, Pharmaceutical Quality System  Pharmacopeias (USP, European)

  14. THANK YOU

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend